These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 17689377
21. Validity of self-reported adherence among injection drug users. Kerr T, Hogg RS, Yip B, Tyndall MW, Montaner J, Wood E. J Int Assoc Physicians AIDS Care (Chic); 2008; 7(4):157-9. PubMed ID: 18626123 [Abstract] [Full Text] [Related]
22. Successive switching of antiretroviral therapy is associated with high psychological and physical burden. Sherr L, Lampe F, Norwood S, Leake-Date H, Fisher M, Edwards S, Arthur G, Anderson J, Zetler S, Johnson M, Harding R. Int J STD AIDS; 2007 Oct; 18(10):700-4. PubMed ID: 17945049 [Abstract] [Full Text] [Related]
23. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan. Liu JY, Lin HH, Liu YC, Lee SS, Chen YL, Hung CC, Ko WC, Huang CK, Lai CH, Chen YS, Shih YL, Chung HC, Liang SH, Lin JN. Clin Infect Dis; 2008 Jun 01; 46(11):1761-8. PubMed ID: 18433337 [Abstract] [Full Text] [Related]
24. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women. Kapadia F, Vlahov D, Wu Y, Cohen MH, Greenblatt RM, Howard AA, Cook JA, Goparaju L, Golub E, Richardson J, Wilson TE. Am J Drug Alcohol Abuse; 2008 Jun 01; 34(2):161-70. PubMed ID: 18293232 [Abstract] [Full Text] [Related]
25. Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerability. Préau M, Protopopescu C, Raffi F, Rey D, Chêne G, Marcellin F, Perronne C, Ragnaud JM, Leport C, Spire B, Anrs Co8 Aproco-Copilote Study Group. AIDS Care; 2012 Jun 01; 24(4):434-43. PubMed ID: 21999644 [Abstract] [Full Text] [Related]
26. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach. Birkhead GS, Klein SJ, Candelas AR, O'Connell DA, Rothman JR, Feldman IS, Tsui DS, Cotroneo RA, Flanigan CA. Int J Drug Policy; 2007 Oct 01; 18(5):417-25. PubMed ID: 17854731 [Abstract] [Full Text] [Related]
27. Neurocognitive aspects of medication adherence in HIV-positive injecting drug users. Waldrop-Valverde D, Ownby RL, Wilkie FL, Mack A, Kumar M, Metsch L. AIDS Behav; 2006 May 01; 10(3):287-97. PubMed ID: 16485072 [Abstract] [Full Text] [Related]
28. Access to highly active antiretroviral therapy (HAART) for injecting drug users in the WHO European Region 2002-2004. Donoghoe MC, Bollerup AR, Lazarus JV, Nielsen S, Matic S. Int J Drug Policy; 2007 Aug 01; 18(4):271-80. PubMed ID: 17689375 [Abstract] [Full Text] [Related]
29. HIV-infected injection drug users: health care utilization and morbidity. Barash ET, Hanson DL, Buskin SE, Teshale E. J Health Care Poor Underserved; 2007 Aug 01; 18(3):675-86. PubMed ID: 17675722 [Abstract] [Full Text] [Related]
30. Evidence-based, multifactorial approach to addressing non-adherence to antiretroviral therapy and improving standards of care. Herrmann S, McKinnon E, John M, Hyland N, Martinez OP, Cain A, Turner K, Coombs A, Manolikos C, Mallal S. Intern Med J; 2008 Jan 01; 38(1):8-15. PubMed ID: 17916167 [Abstract] [Full Text] [Related]
31. HIV infection and high-risk behaviors in opioid dependent patients: the Indian context. Vaswani M, Desai NG. Addict Behav; 2004 Nov 01; 29(8):1699-705. PubMed ID: 15451140 [Abstract] [Full Text] [Related]
32. Respondent-driven sampling to assess characteristics and estimate the number of injection drug users in Bangkok, Thailand. Wattana W, van Griensven F, Rhucharoenpornpanich O, Manopaiboon C, Thienkrua W, Bannatham R, Fox K, Mock PA, Tappero JW, Levine WC. Drug Alcohol Depend; 2007 Oct 08; 90(2-3):228-33. PubMed ID: 17507180 [Abstract] [Full Text] [Related]
33. Predictors of mortality among injecting and non-injecting HIV-negative drug users in northern Thailand. Quan VM, Vongchak T, Jittiwutikarn J, Kawichai S, Srirak N, Wiboonnatakul K, Razak MH, Suriyanon V, Celentano DD. Addiction; 2007 Mar 08; 102(3):441-6. PubMed ID: 17298652 [Abstract] [Full Text] [Related]
34. The opinions of injecting drug user (IDUs) HIV patients and health professionals on access to antiretroviral treatment and health services in Valencia, Spain. Garcia de la Hera M, Davo MC, Ballester-Añón R, Vioque J. Eval Health Prof; 2011 Sep 08; 34(3):349-61. PubMed ID: 21411470 [Abstract] [Full Text] [Related]
36. Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programmes. Bruneau J, Daniel M, Kestens Y, Zang G, Généreux M. J Epidemiol Community Health; 2008 Sep 08; 62(9):804-10. PubMed ID: 18701731 [Abstract] [Full Text] [Related]
37. Self-reported alcohol consumption and its association with adherence and outcome of antiretroviral therapy in the Swiss HIV Cohort Study. Conen A, Fehr J, Glass TR, Furrer H, Weber R, Vernazza P, Hirschel B, Cavassini M, Bernasconi E, Bucher HC, Battegay M, Swiss HIV Cohort Study. Antivir Ther; 2009 Sep 08; 14(3):349-57. PubMed ID: 19474469 [Abstract] [Full Text] [Related]
39. Five-year experience with scaling-up access to antiretroviral treatment in an HIV care programme in Cambodia. Thai S, Koole O, Un P, Ros S, De Munter P, Van Damme W, Jacques G, Colebunders R, Lynen L. Trop Med Int Health; 2009 Sep 08; 14(9):1048-58. PubMed ID: 19573140 [Abstract] [Full Text] [Related]
40. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital. Liang SH, Lo YC, Lin HH, Chang SY, Chen MY, Hsieh SM, Sheng WH, Sun HY, Hung CC, Chang SC. J Microbiol Immunol Infect; 2008 Jun 08; 41(3):200-8. PubMed ID: 18629414 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]